4804
Use of Gamma Globulin in Clinical Practice: Indications, Challenges, Adverse Reactions and Monitoring
Monday, March 3, 2014: 4:45 PM-6:00 PM
Convention Center, Upper Level, Room 5AB
1.25 CME/ 1.50 CE
Moderator:
Elena E. Perez , MD PhD FAAAAI
Primary Panelists:
Mark Ballow , MD FAAAAI
Rima A. Rachid , MD FAAAAI
Vivian P. Hernandez-Trujillo , MD FAAAAI
Learning Objectives:
  1. Discuss the relative virtues of intravenous and subcutaneous IgG therapy
  2. Review common approaches to reducing the systemic side effects of IGIV and managing adverse reactions
  3. Discuss how to optimize IgG replacement therapy in immunodeficiency patients to minimize infections and maintain appropriate levels of Ig with maximal benefit
Handouts
  • Session 4804 Use of gamma globulin in clinical practice.pdf (61.4 kB)